Report overview
Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production. This report contains market size and forecasts of Induced Pluripotent Stem Cells Production in global, including the following market information:
Global Induced Pluripotent Stem Cells Production Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Induced Pluripotent Stem Cells Production Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Induced Pluripotent Stem Cells Production companies in 2022 (%)
The global Induced Pluripotent Stem Cells Production market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatocytes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Induced Pluripotent Stem Cells Production manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Induced Pluripotent Stem Cells Production Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Type, 2022 (%)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Global Induced Pluripotent Stem Cells Production Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, by Application, 2022 (%)
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
Global Induced Pluripotent Stem Cells Production Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Induced Pluripotent Stem Cells Production Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Induced Pluripotent Stem Cells Production revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Induced Pluripotent Stem Cells Production revenues share in global market, 2022 (%)
Key companies Induced Pluripotent Stem Cells Production sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Induced Pluripotent Stem Cells Production sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Induced Pluripotent Stem Cells Production, market overview.
Chapter 2: Global Induced Pluripotent Stem Cells Production market size in revenue and volume.
Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Induced Pluripotent Stem Cells Production capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
